Imnovid® 4 mg
Hard capsule
registration number
49/32.2/0747
What Imnovid® 4 mg contains
Pomalidomide.
other ingredients
Mannitol, pregelatinised starch, sodium stearyl fumarate and a gelatin capsule shell.
Capsule shell:
4 mg capsule shell contains gelatin, titanium dioxide (E171), indigotine (E132), brilliant blue FCF (E133) and white ink.
Printing ink:
4 mg capsule shell contains: white ink – shellac, titanium dioxide (E171), simethicone, propylene glycol (E1520) and ammonium hydroxide (E527).
Therapeutic classification
L04AX06.